Numinus Wellness Announces Strategic Acquisition of MedBright AI
Plans name change to “Numinus Intelligence” leveraging its current revenue-generating operations to AI-enable mental health clinics across the U.S.
VANCOUVER, BC, June 20, 2024 /PRNewswire/ – Numinus Wellness Inc. (“Numinus” or the “Company“) (TSX:NUMI) (OTCQX: NUMIF) (FSE: LR23), a mental healthcare company advancing traditional and innovative behavioral health treatments including safe, evidence-based psychedelic-assisted therapies, announces execution of a letter of intent (the “LOI“) to acquire MedBright AI Investments Inc. (“MedBright AI“) (CSE: MBAI) by way of a statutory plan of arrangement (the “Proposed Transaction“).
Related news for (NUMIF)
- Numinus Wellness Inc. Announces CFO Transition
- Numinus Wellness Inc. Announces Strategic Wind-Down of Non-Operating Subsidiaries
- Numinus Wellness Announces Corporate Update
- Numinus Wellness Closes Sale of Clinics and Launches Initiative to Increase Access to Mental Health Care
- Numinus Wellness Announces Sale of Clinics and Unique Data Partnership to Increase Access to Mental Health Care